ARS Pharmaceuticals, Inc. (SPRY) Dividend History

Company News

• ARS Pharmaceuticals Files for Approval of neffy® in Canada and the United Kingdom on Behalf of Licensing Partner ALK-Abelló A/S

  ARS Pharmaceuticals has filed for approval of its epinephrine nasal spray 'neffy' in Canada and the United Kingdom, where it will be marketed as 'EURneffy', on behalf of its licensing partner ALK-Abelló A/S. The filing is part of the company's efforts to expand the global availability of this life-saving treatment for severe allergic reactions.

  GlobeNewswire Inc.
• ARSファーマシューティカルズ (ARS Pharmaceuticals)、neffy®の中国、日本、オーストラリアでの承認申請を発表

  ARS Pharmaceuticals announced that its licensing partners in China, Japan, and Australia have filed for regulatory approval of its epinephrine nasal spray, neffy, for the treatment of type I allergic reactions including anaphylaxis. The company is focused on making this life-saving treatment widely available globally.

  GlobeNewswire Inc.
• ARS Pharmaceuticals 宣布在中国、日本和澳大利亚申请批准 neffy®

  ARS Pharmaceuticals, a biopharmaceutical company, announced that its authorized partners in China, Japan, and Australia have submitted applications for the approval of the 2 mg dose of neffy, its epinephrine nasal spray, in their respective countries. The 2 mg dose of neffy was recently approved in the US for the treatment of type I allergic reactions, including anaphylaxis, in adults and children weighing at least 30 kg.

  GlobeNewswire Inc.
• ARS Pharmaceuticals Announces Filings for Approval of neffy® in China, Japan and Australia

  ARS Pharmaceuticals' licensing partners in China, Japan, and Australia have filed for approval of their epinephrine nasal spray 'neffy' 2 mg with regulatory agencies in their respective countries. The product has already been approved in the U.S. and EU for the emergency treatment of severe allergic reactions.

  GlobeNewswire Inc.
• The Physician-Patient Alliance for Health & Safety Expands Board of Advisors with Five Healthcare Industry Leaders, Enhancing Commitment to Patient Safety and Innovation

  The Physician-Patient Alliance for Health and Safety (PPAHS) has welcomed five new members to its Board of Advisors, bringing diverse expertise from various healthcare sectors. The new members are expected to enhance PPAHS's commitment to patient safety and innovation.

  GlobeNewswire Inc.

  Featured Companies: ABBV ANTM